Patel Kinnari 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Apr 10, 2025
Insider Transaction Report
Form 4
Patel Kinnari
See Remarks
Transactions
- Purchase
Common Stock
2025-04-09$4.70/sh+21,099$99,165→ 26,774 total(indirect: By Spouse)
Holdings
- 444,103
Common Stock
- 104,927(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]On April 9, 2025, the Reporting Person's husband purchased 21,099 shares of Common Stock in a series of brokered transactions at prices ranging from $4.65 to $4.78 and a weighted average price per share of $4.70 (rounded to two decimal places), for an aggregate purchase price of approximately $99,157. The detailed breakdown of executed sales will be furnished upon request.
- [F2]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F3]The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband.